Péter Sandy
Sarah Cannon · 56 works · 8,980 citations · h-index 25
Top works
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
- Targeting MYC dependence in cancer by inhibiting BET bromodomains
- Activation of p53 by conjugation to the ubiquitin‐like protein SUMO‐1
- Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells
- AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer
- Regulation of p53 activity in nuclear bodies by a specific PML isoform
- The Ubiquitin Ligase FBXW7 Modulates Leukemia-Initiating Cell Activity by Regulating MYC Stability
- Glycogen Synthase Kinase-3β Regulates NF-κB1/p105 Stability
- Mammalian RNAi: a Practical Guide
- Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors
- Identification of EZH2 and EZH1 Small Molecule Inhibitors with Selective Impact on Diffuse Large B Cell Lymphoma Cell Growth
- Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials
- RNAI AS AN EXPERIMENTAL AND THERAPEUTIC TOOL TO STUDY AND REGULATE PHYSIOLOGICAL AND DISEASE PROCESSES
- The Cell Cycle-regulated Protein Human GTSE-1 Controls DNA Damage-induced Apoptosis by Affecting p53 Function
- The PDZ Protein Tax-interacting Protein-1 Inhibits β-Catenin Transcriptional Activity and Growth of Colorectal Cancer Cells
- Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
- Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors
- Requirement of c-Jun NH 2 -Terminal Kinase for Ras-Initiated Tumor Formation
- Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma
- p53 is involved in the p120E4F-mediated growth arrest